"DNA Methylation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Addition of methyl groups to DNA. DNA methyltransferases (DNA methylases) perform this reaction using S-ADENOSYLMETHIONINE as the methyl group donor.
| Descriptor ID |
D019175
|
| MeSH Number(s) |
G02.111.035.538.161 G02.111.218 G03.059.538.161 G05.206
|
| Concept/Terms |
DNA Methylation- DNA Methylation
- DNA Methylations
- Methylation, DNA
- Methylations, DNA
|
Below are MeSH descriptors whose meaning is more general than "DNA Methylation".
Below are MeSH descriptors whose meaning is more specific than "DNA Methylation".
This graph shows the total number of publications written about "DNA Methylation" by people in this website by year, and whether "DNA Methylation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 1 | 3 |
| 1997 | 1 | 6 | 7 |
| 1998 | 4 | 6 | 10 |
| 1999 | 6 | 4 | 10 |
| 2000 | 10 | 8 | 18 |
| 2001 | 20 | 11 | 31 |
| 2002 | 19 | 12 | 31 |
| 2003 | 35 | 16 | 51 |
| 2004 | 23 | 19 | 42 |
| 2005 | 29 | 17 | 46 |
| 2006 | 28 | 26 | 54 |
| 2007 | 28 | 29 | 57 |
| 2008 | 27 | 20 | 47 |
| 2009 | 31 | 16 | 47 |
| 2010 | 30 | 32 | 62 |
| 2011 | 28 | 39 | 67 |
| 2012 | 28 | 35 | 63 |
| 2013 | 32 | 52 | 84 |
| 2014 | 35 | 35 | 70 |
| 2015 | 41 | 28 | 69 |
| 2016 | 34 | 41 | 75 |
| 2017 | 42 | 37 | 79 |
| 2018 | 37 | 47 | 84 |
| 2019 | 35 | 30 | 65 |
| 2020 | 24 | 39 | 63 |
| 2021 | 25 | 31 | 56 |
| 2022 | 10 | 26 | 36 |
| 2023 | 9 | 30 | 39 |
| 2024 | 29 | 19 | 48 |
To return to the timeline,
click here.
Below are the most recent publications written about "DNA Methylation" by people in Profiles.
-
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax?+?Hypomethylating Agent. Am J Hematol. 2025 Feb; 100(2):260-271.
-
Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial. JAMA Oncol. 2024 Dec 01; 10(12):1637-1644.
-
Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1. Mol Carcinog. 2025 Jan; 64(1):44-56.
-
The DNA demethylase TET1 modifies the impact of maternal folic acid status on embryonic brain development. EMBO Rep. 2025 Jan; 26(1):175-199.
-
Interplay of Reactive Oxygen Species (ROS) and Epigenetic Remodelling in Cardiovascular Diseases Pathogenesis: A Contemporary Perspective. Front Biosci (Landmark Ed). 2024 Nov 21; 29(11):398.
-
Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer. Clin Cancer Res. 2024 Nov 15; 30(22):5166-5179.
-
DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sites. Clin Epigenetics. 2024 Nov 10; 16(1):156.
-
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance. JCO Precis Oncol. 2024 Nov; 8:e2400375.
-
3D genome topology distinguishes molecular subgroups of medulloblastoma. Am J Hum Genet. 2024 Dec 05; 111(12):2720-2734.
-
Stem cell activity-coupled suppression of endogenous retrovirus governs adult tissue regeneration. Cell. 2024 Dec 26; 187(26):7414-7432.e26.